Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner

Direct 3D Printed Biomimetic Scaffolds Based on Hydrogel Microparticles for Cell Spheroid Growth

(2020) Hua Zhang et al.   ADVANCED FUNCTIONAL MATERIALS

Engineering Stimuli‐Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy

(2020) Bo Hou et al.   ADVANCED MATERIALS

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

(2020) John D. Martin et al.   Nature Reviews Clinical Oncology

Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses

(2020) Yu Chao et al.   Science Advances

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine

(2020) Caroline Boudousquié et al.   Vaccines

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy

(2020) Jing Gao et al.   ACTA PHARMACOLOGICA SINICA

Biomaterials as Local Niches for Immunomodulation

(2020) Kwasi Adu-Berchie et al.   ACCOUNTS OF CHEMICAL RESEARCH

Antitumour dendritic cell vaccination in a priming and boosting approach

(2020) Alexandre Harari et al.   NATURE REVIEWS DRUG DISCOVERY

A biodegradable thermosensitive hydrogel vaccine for cancer immunotherapy

(2020) Fan Yang et al.   Applied Materials Today

Engineered Nanoparticles for Cancer Vaccination and Immunotherapy

(2020) Marisa E. Aikins et al.   ACCOUNTS OF CHEMICAL RESEARCH

An implantable blood clot–based immune niche for enhanced cancer vaccination

(2020) Qin Fan et al.   Science Advances

Delivery technologies for cancer immunotherapy

(2019) Rachel S. Riley et al.   NATURE REVIEWS DRUG DISCOVERY

Sustained co-delivery of gemcitabine and cis-platinum via biodegradable thermo-sensitive hydrogel for synergistic combination therapy of pancreatic cancer

(2019) Kun Shi et al.   Nano Research

Cy5.5-MSA-G250 nanoparticles (CMGNPs) induce M1 polarity of RAW264. 7 macrophage cells via TLR4-dependent manner

(2019) Zhuoxuan Lu et al.   CHINESE CHEMICAL LETTERS

Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy

(2019) Xinyu Ye et al.   ACS Nano

Intrinsic cancer vaccination

(2019) Yoosoo Yang et al.   ADVANCED DRUG DELIVERY REVIEWS

Anti-Tumor Activity of Mannose-CpG-Oligodeoxynucleotides-Conjugated and Hepatoma Lysate-Loaded Nanoliposomes for Targeting Dendritic Cells In Vivo

(2019) Xiaomei Yang et al.   Journal of Biomedical Nanotechnology

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

(2019) Wei Yang et al.   NATURE MEDICINE

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

(2019) Leonie Voorwerk et al.   NATURE MEDICINE

Mannosylated PEGylated-Polyethyleneimine as Efficient CpG Oligodeoxynucleotide Carriers for Efficient Dendritic Cell Targeting Delivery and Activation

(2019) Junfeng Liu et al.   Journal of Biomedical Nanotechnology

Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment

(2019) Hongjuan Zhao et al.   ACS Nano

In Situ Formed Fibrin Scaffold with Cyclophosphamide to Synergize with Immune Checkpoint Blockade for Inhibition of Cancer Recurrence after Surgery

(2019) Lin Zhang et al.   ADVANCED FUNCTIONAL MATERIALS

Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy

(2018) Junjie Wu et al.   CANCER LETTERS

Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant

(2018) Zhifang Zhou et al.   CHINESE CHEMICAL LETTERS

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

(2018) Janos L. Tanyi et al.   Science Translational Medicine

Multifunctional Chitosan Inverse Opal Particles for Wound Healing

(2018) Canwen Chen et al.   ACS Nano

Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer

(2018) Xiangsheng Liu et al.   ACS Nano

Real-Time Imaging Tracking of a Dual Fluorescent Vaccine Delivery System Based on Ovalbumin Loaded Zinc Phthalocyanine-Incorporated Copolymer Nanoparticles

(2018) Chang Wei et al.   Journal of Biomedical Nanotechnology

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

(2018) Derin B. Keskin et al.   NATURE

An immunogenic personal neoantigen vaccine for patients with melanoma

(2017) Patrick A. Ott et al.   NATURE

Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients

(2017) Eva Bräunlein et al.   Frontiers in Immunology

Co-delivery of chemotherapeutics and proteins for synergistic therapy

(2016) Chaoliang He et al.   ADVANCED DRUG DELIVERY REVIEWS

Designer vaccine nanodiscs for personalized cancer immunotherapy

(2016) Rui Kuai et al.   NATURE MATERIALS

Synthesis, characterization, and application of reversible PDLLA-PEG-PDLLA copolymer thermogels in vitro and in vivo

(2016) Kun Shi et al.   Scientific Reports

Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance

(2015) Irina Kareva et al.   CANCER LETTERS

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model

(2014) Junjie Wu et al.   CANCER LETTERS

Tumor lysate-loaded biodegradable microparticles as cancer vaccines

(2013) Vijaya B Joshi et al.   Expert Review of Vaccines

Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides

(2012) P. Filipazzi et al.   CLINICAL CANCER RESEARCH

Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies

(2011) L. A. Marr et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients

(2008) B. G. Molenkamp et al.   CLINICAL CANCER RESEARCH